WaveMan
WaveMan · Company
OFIX · Orthofix Medical Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

OFIX Orthofix Medical (OFIX) Insider Trading, Ownership & Congress Trades

Medical Devices · Surgical & medical instruments & apparatus · CIK 0000884624
Quote by TradingView
Cluster · 3 insidersForm 144 · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
86
13F, latest reported quarter

What the filings say about OFIX

Insiders, 180 days
-$748.4K net sold
3 buyers · 3 sellers · 22% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$4.2K
1 notice

Orthofix Medical insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Orthofix Medical Inc. insiders sold a net $748.4K of stock across 84 Form 4 purchases and sales, with 3 insiders buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Fisher Patrick
President, Global Limb Recon
SELL
2026-10-05 SECtraded 2026-10-01
150
$1.4K
+4.3%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Sep 1, 2026.
  • The trade is 0.3% of the 50,919 shares held after it.
  • 1 other insider sold within 30 days.
  • 86 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President, Global Limb Recon Fisher Patrick sold about $1.4K of OFIX under a 10b5-1 plan on Oct 1, 2026; 1 other insider sold within 30 days and 86 funds added in the latest 13F quarter.
Juniper Investment Company, LLC
SELL
2026-09-22 SECtraded 2026-09-21
190,000
$1.7M
+6.9%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (1 buy, 4 sales), the last on Sep 18, 2026.
  • The trade is 5.0% of the 3,771,216 shares held after it.
  • 1 other insider sold within 30 days.
  • 86 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Juniper Investment Company, LLC sold about $1.7M of OFIX on Sep 21, 2026; 1 other insider sold within 30 days and 86 funds added in the latest 13F quarter.
Juniper Investment Company, LLC
BUY
2026-09-23 SECtraded 2026-09-21
190,000
$1.7M
+7.1%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (1 buy, 4 sales), the last on Sep 18, 2026.
  • The trade is 5.0% of the 3,771,216 shares held after it.
  • No other insider bought within 30 days.
  • 86 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Juniper Investment Company, LLC bought about $1.7M of OFIX on Sep 21, 2026, the largest insider purchase at the company on our record; 86 funds added in the latest 13F quarter.
Juniper Investment Company, LLC
SELL
2026-09-22 SECtraded 2026-09-18
120,000
$1.0M
+6.9%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Aug 17, 2026.
  • The trade is 3.4% of the 3,581,216 shares held after it.
  • 1 other insider sold within 30 days.
  • 86 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Juniper Investment Company, LLC sold about $1.0M of OFIX on Sep 18, 2026; 1 other insider sold within 30 days and 86 funds added in the latest 13F quarter.
Juniper Investment Company, LLC
BUY
2026-09-23 SECtraded 2026-09-18
120,000
$1.0M
+7.1%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Aug 17, 2026.
  • The trade is 3.4% of the 3,581,216 shares held after it.
  • No other insider bought within 30 days.
  • 86 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Juniper Investment Company, LLC bought about $1.0M of OFIX on Sep 18, 2026; 86 funds added in the latest 13F quarter.
84 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 79 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$748.4K over 180 days
-$418.6K over 90 days · -$759.4K of it by a 10%+ holder
below 60% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
86 funds bought in last quarter
more than 59% of Medical Devices
Revenue
+2.9% year over year
below 70% of Medical Devices
Margin
-11.2% net margin
more than 55% of Medical Devices
Buybacks
no share repurchases reported
Short interest
6.0% of the float short (float per yahoo 2026-10-26) · 5.5 days to cover · settled 2026-09-30
more than 69% of Medical Devices
What changed in the last 30 days
Oct 5President, Global Limb Recon Fisher Patrick sold $1.4K under a 10b5-1 plan (Oct 1)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.

Watch OFIX

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-39.6%12M
-47%-31%-16%+0%2025-102025-122026-022026-042026-062026-082026-10 2026-05-22 · Juniper Investment Company, LLC sold $2.6M2026-09-21 · Juniper Investment Company, LLC bought $1.7M2026-09-21 · Juniper Investment Company, LLC sold $1.7M2026-02-24 · Ajdler Arnaud bought $1.5M2026-05-05 · Engine Jet Capital, L.P. bought $1.3M2026-09-18 · Juniper Investment Company, LLC bought $1.0M2026-09-18 · Juniper Investment Company, LLC sold $1.0M2026-05-06 · Engine Jet Capital, L.P. bought $466.6K2026-05-07 · Engine Jet Capital, L.P. bought $221.9K2026-08-14 · Juniper Investment Company, LLC sold $202.5K2026-08-17 · Juniper Investment Company, LLC sold $200.3K2026-01-09 · Calafiore Massimo sold $151.9K2026-01-12 · Calafiore Massimo sold $149.0K2026-02-25 · Ajdler Arnaud bought $129.1K2026-05-07 · Engine Jet Capital, L.P. bought $110.5K2026-02-24 · Ajdler Arnaud bought $96.9K2026-03-04 · Calafiore Massimo sold $80.0K2026-03-05 · Calafiore Massimo sold $75.7K2026-01-16 · Andrews Julie sold $70.1K2026-05-07 · HENNEMAN JOHN B III bought $61.3K2026-03-17 · Vitale Lucas sold $50.9K2026-04-16 · Cedron Jorge Andres sold $48.0K2026-05-06 · Engine Jet Capital, L.P. bought $46.4K2026-02-25 · Ajdler Arnaud bought $40.2K2026-05-05 · Engine Jet Capital, L.P. bought $34.9K2026-06-18 · McPherron Aviva sold $34.4K2026-03-04 · Andrews Julie sold $31.3K2026-03-09 · CAPPS VICKIE L bought $31.2K2026-03-10 · CAPPS VICKIE L bought $29.9K2026-03-05 · Andrews Julie sold $29.7K2026-05-07 · Engine Jet Capital, L.P. bought $22.1K2026-03-04 · Cedron Jorge Andres sold $18.2K2026-03-05 · Cedron Jorge Andres sold $17.2K2026-03-04 · McPherron Aviva sold $16.7K2026-03-05 · McPherron Aviva sold $15.9K2026-03-04 · Vitale Lucas sold $15.1K2026-03-05 · Vitale Lucas sold $14.3K2026-03-04 · REINHARDT MAX sold $14.0K2026-03-05 · REINHARDT MAX sold $13.2K2026-08-18 · Fisher Patrick sold $13.1K2026-05-07 · Engine Jet Capital, L.P. bought $11.0K2026-03-04 · Fisher Patrick sold $10.1K2026-09-01 · PATRICK FISHER filed to sell $4.2K
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns OFIX: institutional holders (13F)

13F holdings, latest reported quarter
Engine Capital Management, LP
4,575,675 sh
$41.8M
Juniper Investment Company, LLC
4,442,543 sh
$40.6M
Rubric Capital Management LP
3,721,715 sh
$34.0M
BlackRock, Inc.
3,326,560 sh
$30.4M
PARADIGM CAPITAL MANAGEMENT INC/NY
3,300,499 sh
$30.2M

Congress trades in OFIX

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

OFIX planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
PATRICK FISHER
Filed 2026-09-01
$4.2K

OFIX mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Paradigm Micro-Cap Fund
$3.7M position · as of 2026-06-30
2.0%
Paradigm Value Fund
$731.2K position · as of 2026-06-30
1.3%
Victory Integrity Discovery Fund
$530.1K position · as of 2026-06-30
0.6%
Dunham Small Cap Value Fund
$436.5K position · as of 2026-07-31
0.5%
State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF
$672.6K position · as of 2026-06-30
0.4%
Paradigm Select Fund
$914.0K position · as of 2026-06-30
0.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Jon CSerbousek
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2022
$6.3M
$5.0M
$2.1M
-56%
+21%
2021
$5.3M
$723.4K
$1.8M
-33%
+70%
2020
$5.3M
$6.8M
$1.5M
-7%
+46%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
3 insiders reported buying shares.
The record shows a net $748.4K sold by insiders over 180 days, 86 funds added last quarter, $4.2K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

OFIX financials

Revenue growth
+2.9%
XBRL, annual
Net margin
-11.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$833.2M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-7.4%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$27.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.52x
long-term 2026-06-30 plus current 2025-12-31 (6 months older than the period end); equity 2026-06-30
Cash flow to debt
0.07x
TTM operating cash flow over long-term 2026-06-30 plus current 2025-12-31 (6 months older than the period end)
Return on equity
-13.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-7.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-5.6%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$517.4M
market value at close 2026-10-23 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2025-12-31 (6 months older than the period end), minus cash 2026-06-30
FCF yield
-7.0%
TTM free cash flow over market value at close 2026-10-23
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$822.3M$799.5M$746.6M$460.7M
Gross profit$566.0M$545.9M$486.3M$337.2M
Operating income-$81.4M-$84.6M-$139.1M-$13.3M
Net income-$92.2M-$126.0M-$151.4M-$19.8M
EPS (diluted)-2.33-3.30-4.12-0.98
Operating cash flow$33.3M$25.8M-$45.8M-$11.5M
Cash$82.0M$83.2M$33.1M$50.7M
Long-term debt$157.4M$157.0M$93.1Mn/a
SEC XBRL, fiscal years, as known on 2026-10-27

OFIX Stock Sonar score 6/7 axes

Find similar shapesCompare

OFIX ranks highest on risk and compliance (78th percentile) and insider conviction (61st), and lowest on growth (30th), among Medical Devices peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
59
Inputs
  • Return on equity-13.9% · 54 pct, sector of 183
  • Return on assets-7.2% · 60 pct, sector of 214
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-5.6% · 62 pct, sector of 188
Financial health
48
Inputs
  • Debt to equity0.52x · 38 pct, sector of 159
  • Cash flow to debt0.07x · 58 pct, sector of 150
Growth
30
Inputs
  • Revenue growth, YoY+2.9% · 30 pct, sector of 219
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
61
Inputs
  • Net Form 4 buying (codes P and S), 180d-$746K · 38 pct, sector of 140
  • Insider buyers, 180d3 · 84 pct, sector of 142
Institutional and government
59
Inputs
  • Funds adding, latest quarter86 · 59 pct, sector of 191
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
78
Inputs
  • Short interest, % of float+6.0% · 42 pct, sector of 240
  • Recalls per $1B revenue, 3y0.00 per $1B · 100 pct, sector of 116
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+2.8% · 91 pct, sector of 198
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

OFIX filings, in plain words

Are Orthofix Medical insiders buying or selling OFIX?

In the 180 days to 2026-10-27, Orthofix Medical insiders were net sellers, a net $748.4K: $5.0M of purchases and $5.8M of sales reported on Form 4, by 3 buyers and 3 sellers.

Are there planned insider sales of OFIX?

Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-27, covering $4.2K of stock; the latest, by PATRICK FISHER, was filed 2026-09-01.

Read the full summary

In the 180 days to 2026-10-27, Orthofix Medical insiders were net sellers of OFIX, a net $748.4K across purchases and sales reported on Form 4 by 3 buyers and 3 sellers. Most of that figure, $759.4K, came from a holder of 10% or more rather than an officer or director. 3 insiders reported purchases in that window. 22% of the 9 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-27, covering $4.2K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies